Literature DB >> 19549897

Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells.

Pei-Yin Hsu1, Daniel E Deatherage, Benjamin A T Rodriguez, Sandya Liyanarachchi, Yu-I Weng, Tao Zuo, Joseph Liu, Alfred S L Cheng, Tim H-M Huang.   

Abstract

Early exposure to xenoestrogens may predispose to breast cancer risk later in adult life. It is likely that long-lived, self-regenerating epithelial progenitor cells are more susceptible to these exposure injuries over time and transmit the injured memory through epigenetic mechanisms to their differentiated progeny. Here, we used progenitor-containing mammospheres as an in vitro exposure model to study this epigenetic effect. Expression profiling identified that, relative to control cells, 9.1% of microRNAs (82 of 898 loci) were altered in epithelial progeny derived from mammospheres exposed to a synthetic estrogen, diethylstilbestrol. Repressive chromatin marks, trimethyl Lys27 of histone H3 (H3K27me3) and dimethyl Lys9 of histone H3 (H3K9me2), were found at a down-regulated locus, miR-9-3, in epithelial cells preexposed to diethylstilbestrol. This was accompanied by recruitment of DNA methyltransferase 1 that caused an aberrant increase in DNA methylation of its promoter CpG island in mammosphere-derived epithelial cells on diethylstilbestrol preexposure. Functional analyses suggest that miR-9-3 plays a role in the p53-related apoptotic pathway. Epigenetic silencing of this gene, therefore, reduces this cellular function and promotes the proliferation of breast cancer cells. Promoter hypermethylation of this microRNA may be a hallmark for early breast cancer development, and restoration of its expression by epigenetic and microRNA-based therapies is another viable option for future treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549897      PMCID: PMC2855843          DOI: 10.1158/0008-5472.CAN-08-4914

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

Review 1.  The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3.

Authors:  Ru Cao; Yi Zhang
Journal:  Curr Opin Genet Dev       Date:  2004-04       Impact factor: 5.578

Review 2.  DNA methylation and human disease.

Authors:  Keith D Robertson
Journal:  Nat Rev Genet       Date:  2005-08       Impact factor: 53.242

Review 3.  Estrogen carcinogenesis in breast cancer.

Authors:  James D Yager; Nancy E Davidson
Journal:  N Engl J Med       Date:  2006-01-19       Impact factor: 91.245

4.  Diethylstilbestrol usage: Its interesting past, important present, and questionable future.

Authors:  K L Noller; C R Fish
Journal:  Med Clin North Am       Date:  1974-07       Impact factor: 5.456

Review 5.  Endocrine disruptors and reproductive health: the case of bisphenol-A.

Authors:  Maricel V Maffini; Beverly S Rubin; Carlos Sonnenschein; Ana M Soto
Journal:  Mol Cell Endocrinol       Date:  2006-06-15       Impact factor: 4.102

6.  Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry.

Authors:  Mathias Ehrich; Matthew R Nelson; Patrick Stanssens; Marc Zabeau; Triantafillos Liloglou; George Xinarianos; Charles R Cantor; John K Field; Dirk van den Boom
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-21       Impact factor: 11.205

Review 7.  Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences.

Authors:  Suzanne E Fenton
Journal:  Endocrinology       Date:  2006-05-11       Impact factor: 4.736

Review 8.  Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations.

Authors:  Retha R Newbold; Elizabeth Padilla-Banks; Wendy N Jefferson
Journal:  Endocrinology       Date:  2006-05-11       Impact factor: 4.736

9.  Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4.

Authors:  Shuk-Mei Ho; Wan-Yee Tang; Jessica Belmonte de Frausto; Gail S Prins
Journal:  Cancer Res       Date:  2006-06-01       Impact factor: 12.701

10.  MicroRNA gene expression deregulation in human breast cancer.

Authors:  Marilena V Iorio; Manuela Ferracin; Chang-Gong Liu; Angelo Veronese; Riccardo Spizzo; Silvia Sabbioni; Eros Magri; Massimo Pedriali; Muller Fabbri; Manuela Campiglio; Sylvie Ménard; Juan P Palazzo; Anne Rosenberg; Piero Musiani; Stefano Volinia; Italo Nenci; George A Calin; Patrizia Querzoli; Massimo Negrini; Carlo M Croce
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

View more
  53 in total

1.  Aberrant hypermethylation of miR-9 genes in gastric cancer.

Authors:  Kuo-Wang Tsai; Yu-Lun Liao; Chew-Wun Wu; Ling-Yueh Hu; Sung-Chou Li; Wen-Ching Chan; Meng-Ru Ho; Chun-Hung Lai; Hsiao-Wei Kao; Wen-Liang Fang; Kuo-Hung Huang; Wen-chang Lin
Journal:  Epigenetics       Date:  2011-10-01       Impact factor: 4.528

2.  Environmental chemical exposures and human epigenetics.

Authors:  Lifang Hou; Xiao Zhang; Dong Wang; Andrea Baccarelli
Journal:  Int J Epidemiol       Date:  2011-12-13       Impact factor: 7.196

Review 3.  Smad-mediated regulation of microRNA biosynthesis.

Authors:  Matthew T Blahna; Akiko Hata
Journal:  FEBS Lett       Date:  2012-01-28       Impact factor: 4.124

4.  Modulation of MicroRNAs by Chemical Carcinogens and Anticancer Drugs in Human Cancer: Potential Inkling to Therapeutic Advantage.

Authors:  Subrata Haldar; Aruna Basu
Journal:  Mol Cell Pharmacol       Date:  2011-01-01

Review 5.  Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.

Authors:  Zdenko Herceg; Marie-Pierre Lambert; Karin van Veldhoven; Christiana Demetriou; Paolo Vineis; Martyn T Smith; Kurt Straif; Christopher P Wild
Journal:  Carcinogenesis       Date:  2013-06-07       Impact factor: 4.944

6.  Aberrant expression of miR-9/9* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERG.

Authors:  K Nowek; S M Sun; L Bullinger; E M J Bindels; C Exalto; M K Dijkstra; K van Lom; H Döhner; S J Erkeland; B Löwenberg; M Jongen-Lavrencic
Journal:  Leukemia       Date:  2015-07-15       Impact factor: 11.528

Review 7.  Environmental exposures, stem cells, and cancer.

Authors:  Tasha Thong; Chanese A Forté; Evan M Hill; Justin A Colacino
Journal:  Pharmacol Ther       Date:  2019-07-31       Impact factor: 12.310

8.  MicroRNA 9-3p targets β1 integrin to sensitize claudin-low breast cancer cells to MEK inhibition.

Authors:  Jon S Zawistowski; Kazuhiro Nakamura; Joel S Parker; Deborah A Granger; Brian T Golitz; Gary L Johnson
Journal:  Mol Cell Biol       Date:  2013-03-25       Impact factor: 4.272

Review 9.  DNA methylation and microRNA dysregulation in cancer.

Authors:  Hiromu Suzuki; Reo Maruyama; Eiichiro Yamamoto; Masahiro Kai
Journal:  Mol Oncol       Date:  2012-08-10       Impact factor: 6.603

10.  Developmental programming: gestational bisphenol-A treatment alters trajectory of fetal ovarian gene expression.

Authors:  Almudena Veiga-Lopez; Lacey J Luense; Lane K Christenson; Vasantha Padmanabhan
Journal:  Endocrinology       Date:  2013-03-22       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.